Investing in stocks is akin to navigating a vast ocean of opportunities, where discerning investors can sail towards financial success. Amidst the myriad of investment options available, few strategies have stood the test of time like investing in high-quality dividend stocks.
Recently, investment advisory firm Hartford Funds disseminated a comprehensive report (“The Power of Dividends: Past, Present, and Future”), highlighting the superior performance of dividend-paying stocks when compared to their non-dividend counterparts. Over extended periods, dividend stocks have shone bright like stars in the night sky.
Image source: Getty Images.
According to Hartford Funds in collaboration with Ned Davis Research, dividend-paying companies have boasted an average 9.17% annual return over the last fifty years (1973-2023), with a volatility level 6% lower than the S&P 500. In contrast, non-dividend payers delivered a less impressive 4.27% annualized return over the same period, with 18% higher volatility compared to the benchmark S&P 500.
Despite the collective outperformance of dividend stocks, not all income stocks have emerged as shining stars. Some ultra-high-yield dividend stocks, with yields at least four times higher than the S&P 500’s current yield of 1.34%, have struggled in this bullish market.
However, recent Form 13F filings have revealed that three underperforming yet renowned ultra-high-yield dividend stocks have garnered immense interest among billionaire investors.
The Cautionary Tale of Ford Motor Company: 5.71% yield
Amidst the tumultuous seas of the market, Ford Motor Company emerges as a beacon of high yield, attracting the attention of billionaire investors. Despite recent struggles, four prominent billionaires have placed their bets on Ford during the second quarter:
- Ole Andreas Halvorsen of Viking Global Investors (18,789,638 shares)
- Ken Fisher of Fisher Asset Management (4,825,153 shares)
- Jeff Yass of Susquehanna International (3,645,709 shares)
- Cliff Asness of AQR Capital Management (2,497,695 shares)
The recent downturn in Ford’s stock price can be attributed to challenges such as higher recall costs and anticipated losses in its electric vehicle segment. However, Ford holds the strategic advantage of pivoting its focus towards consumer demands. Notably, Ford’s F-Series pickup has been a bestseller in the U.S. for nearly five decades, underscoring its market clout and profitability.
With a robust capital position and an upward revision of its free cash flow guidance, Ford remains a compelling investment case for billionaire money managers eyeing high yields.
Image source: Getty Images.
Steering Through Challenges with Walgreens Boots Alliance: 9.24% yield
Another ship navigating the stormy waters of the market is the pharmacy giant Walgreens Boots Alliance. Despite facing headwinds, three prominent billionaire investors stood by their faith in Walgreens by acquiring its shares during the June-ended quarter:
- Ken Griffin of Citadel Advisors (608,979 shares)
- Jeff Yass of Susquehanna International (380,334 shares)
- Steven Cohen of Point72 Asset Management (323,532 shares)
Enduring a tumultuous 78% decline in share price over the past five years, Walgreens’ yield has climbed above 9%. Intensifying competition from online pharmacies and initial setbacks in its healthcare transition have contributed to its underperformance. However, with stalwart billionaires backing the company, there may be a glimmer of hope on the horizon.
The Resurgence of Walgreens and AT&T: A Financial analysis
The Walgreens Boots Alliance Turnaround
After facing a significant writedown earlier this year, Walgreens Boots Alliance found itself in a precarious position. The arrival of new CEO, Tim Wentworth, injected a fresh perspective into the healthcare giant’s strategy. Wentworth’s decisive actions, like the closure of underperforming stores, signal a necessary shift in course for the company.
One key component of Wentworth’s revival plan involves streamlining operations. By shedding non-core assets and shutting down ineffective stores, Walgreens aims to bolster its financial standing and enhance flexibility in a rapidly evolving market.
Moreover, Wentworth recognizes the importance of future investments. Embracing digitization, expanding direct-to-consumer channels, and fortifying its healthcare network mark crucial steps towards sustainable growth for Walgreens.
While the transformation may not yield immediate results, Walgreens seems poised to navigate the challenging terrain under Wentworth’s guidance.
AT&T: Navigating the Telecom Landscape
AT&T, a telecom powerhouse, faces its fair share of trials as it endeavors to stay relevant in a dynamic market. Despite recent challenges, the company remains an attractive option for investors, drawing interest from prominent billionaires.
AT&T’s recent struggles, including health-related concerns tied to its infrastructure, have tested its resilience. Nevertheless, the company’s focus on enhancing its network capabilities, especially in the realm of 5G technology, offers a glimmer of hope for its future prospects.
Significantly, AT&T has made considerable strides in strengthening its financial position. With a reduced net debt following the WarnerMedia spin-off, the company appears well-positioned to maintain its impressive dividend yield.
Investors also find appeal in AT&T’s improved balance sheet, demonstrating a commitment to sustainable growth and stability in uncertain times.
Investment Considerations
While both Walgreens and AT&T face unique challenges in their respective industries, they showcase resilience and adaptability in the face of adversity. Investors monitoring these stocks may find opportunities for long-term investment growth.
Considering the evolving landscape of healthcare and telecommunications, strategic moves by Walgreens and AT&T underline the importance of flexibility and foresight in maintaining a competitive edge.
Ultimately, the success of these companies hinges on their ability to innovate, streamline operations, and capitalize on emerging trends in the market.
